SkyePharma (Injectable Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

SkyePharma (Injectable Business) General Information

Description

Manufacturer of liposome injestion. The unit is engaged in the manufacturing and distribution of DepoCyt for lymphomatous meningitis and DepoDur liposome injestions for post-operative pain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • San Diego, CA
  • United States
Primary Industry
Pharmaceuticals
Acquirer
Pacira BioSciences
Vertical(s)
Manufacturing
Corporate Office
  • San Diego, CA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SkyePharma (Injectable Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SkyePharma (Injectable Business)‘s full profile, request access.

Request a free trial

SkyePharma (Injectable Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SkyePharma (Injectable Business)‘s full profile, request access.

Request a free trial

SkyePharma (Injectable Business) FAQs

  • Where is SkyePharma (Injectable Business) headquartered?

    SkyePharma (Injectable Business) is headquartered in San Diego, CA.

  • What industry is SkyePharma (Injectable Business) in?

    SkyePharma (Injectable Business)’s primary industry is Pharmaceuticals.

  • Is SkyePharma (Injectable Business) a private or public company?

    SkyePharma (Injectable Business) is a Private company.

  • What is the current valuation of SkyePharma (Injectable Business)?

    The current valuation of SkyePharma (Injectable Business) is .

  • What is SkyePharma (Injectable Business)’s current revenue?

    The current revenue for SkyePharma (Injectable Business) is .

  • Who are SkyePharma (Injectable Business)’s investors?

    Skyepharma has invested in SkyePharma (Injectable Business).

  • When was SkyePharma (Injectable Business) acquired?

    SkyePharma (Injectable Business) was acquired on 26-Mar-2007.

  • Who acquired SkyePharma (Injectable Business)?

    SkyePharma (Injectable Business) was acquired by Pacira BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »